Cambium Bio Competitors and Similar CompaniesClear all
Cambium Bio's competitors and similar companies include InGeneron, BBI Life Sciences, AavantiBio and Mycenax Biotech.
 Cambium Bio Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology. |  InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. |  AavantiBio AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space. |  Mycenax Biotech Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services. | ||
Founding Date | Founding Date 2007 | Founding Date 2006 | Founding Date 2013 | Founding Date 2020 | Founding Date 2001 |
Type | Type Public | Type Private | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations Paddington, AU HQ Pymble, AU | Locations Houston, US HQ München, DE | Locations CN HQ | Locations Cambridge, US HQ | Locations Zhunan, TW HQ Taipei, TW Zhunan, TW |
Employees | Employees N/A | Employees 16 | Employees 1,588 | Employees 6 | Employees 387 |
Financial | |||||
Revenue (est.) | Revenue (est.) $670k (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥703.8m (FY, 2019) | Revenue (est.) N/A | Revenue (est.) NT$740.2m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥288m (FY, 2019) | Cost of goods N/A | Cost of goods NT$637.3m (FY, 2025) |
Gross profit | Gross profit $1.2m (FY, 2025) | Gross profit N/A | Gross profit ¥417.2m (FY, 2019) | Gross profit N/A | Gross profit NT$114.2m (FY, 2025) |
Net income | Net income ($3.8m) (FY, 2025) | Net income N/A | Net income ¥86m (FY, 2019) | Net income N/A | Net income (NT$448.6m) (FY, 2025) |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round $ 23m (almost 7 years ago) | Latest funding round $ 10.3m (over 11 years ago) | Latest funding round $ 107m (over 5 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised N/A | Total funding raised $ 47.5m | Total funding raised $ 10.3m | Total funding raised $ 107m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
InGeneron
HQ
Houston, US
Employees
16
InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.
View company
BBI Life Sciences
HQ
CN
Employees
1,588
BBI Life Sciences (BBI生命科学) is a supplier of life science products and services.
View companyAavantiBio
HQ
Cambridge, US
Employees
6
AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space.
View companyMycenax Biotech
HQ
Zhunan, TW
Employees
387
Mycenax Biotech (永昕生物醫藥股份有限公司) is a company that provides biopharmaceutical development services.
View company